Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis (PIVOT-LC1-Pi)

Multicenter Randomized Controlled Trial Comparing Early Internal Fixation Versus NonOperative Care With Early Rehabilitation for LC1 Fragility Fractures of the Pelvis: A Pilot Study

The goal of this randomized pilot study is to assess feasibility of the trial and to collect information to inform the design of a definitive trial. Adult patients ages 60 years or older with a low-energy lateral compression type 1 (LC1) pelvis fracture with <10 mm initial displacement of the posterior pelvic ring will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, early internal fixation or nonoperative care with early rehabilitation, defined as at least five days of attempted mobilization by rehabilitation providers. Participants will be followed for 1 year.

Study Overview

• Status: Recruiting
• Conditions: Internal Fixation; Fragility Fracture; Multiple Closed Pelvic Fractures With Disruption of Pelvic Ring; Nonoperative Care
• Intervention / Treatment: Procedure: Early Internal Fixation; Other: Nonoperative Care with Early Rehabilitation

Detailed Description

More than half of fragility fractures of the pelvis in older adults exhibit a lateral compression type 1 fracture pattern (LC1), with fractures of the posterior pelvic ring involving the sacrum bone and a corresponding disruption of the anterior pelvic ring. Nonoperative treatment has remained the standard of care for older adults with minimally displaced (<10 mm) LC1 fragility fractures of the pelvis, as patients are often able to mobilize within a few days with a walking aid. However, preliminary data have suggested that early internal fixation may lead to better patient outcomes, including improved ambulation, shorter hospital stay, less use of opioid pain medication, greater likelihood of returning home after hospital admission, and a lower risk of death compared to nonoperative care. While the preliminary data supporting the use of early internal fixation for minimally displaced LC1 fragility fractures of the pelvis is promising, the necessary evidence to make this significant practice change remains lacking.

The eventual definitive trial has significant potential to change clinical practice and optimize patient outcomes for older adults who experience a minimally displaced LC1 fragility fracture of the pelvis. Treating minimally displaced LC1 fragility fractures of the pelvis with early internal fixation, instead of nonoperative care, would be a paradigm shift in clinical care. This pilot study will demonstrate feasibility of the definitive trial and be used to refine aspects of the study protocol as necessary. If feasibility is successfully demonstrated, the pilot activities will be considered a vanguard phase for the definitive clinical trial.

Adult patients ages 60 years or older with a low-energy lateral compression type 1 (LC1) pelvis fracture with <10 mm initial displacement of the posterior pelvic ring will be eligible to participate in the study. Patients will be randomized to one of two treatment groups, early internal fixation or nonoperative care with early rehabilitation, defined as at least five days of attempted mobilization by rehabilitation providers. Patients will be followed for 1 year, with visits occurring at 2 weeks, 6 weeks, 4 months, 8 months, and 1 year after fracture. At each follow-up, mortality, ambulation, healthy days at home, and health status will be collected.

The primary objective is to assess feasibility of the trial and to collect information to inform the design of the definitive trial. The feasibility outcomes will include participant enrollment, adherence to treatment allocation, data collection methods, and compliance with key aspects of the protocol.

• Study Type: Interventional
• Enrollment (Estimated): 48
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Pui Yan, MS; Phone Number: 323-442-6984; Email: puiyan@med.usc.edu

Study Locations

• Spain
  • Spain
    • Barcelona, Spain, Spain, 08035
      • Not yet recruiting
      • Research Institute Vall d'Hebrón - Vall d'Hebron University Hospital
      • Contact: Jordi Teixidor-Serra, MD; Phone Number: 34 934 89 30 00; Email: email@email.email
      • Principal Investigator: Jordi Teixidor-Serra, MD
• United States
  • Arizona
    • Phoenix, Arizona, United States, 85006
      • Not yet recruiting
      • University of Arizona
      • Contact: Brock Walker, MD; Phone Number: 602-521-3250; Email: Joseph.Walker@bannerhealth.com
      • Principal Investigator: Joseph Walker, MD
  • California
    • Los Angeles, California, United States, 90033
      • Recruiting
      • Keck Medical Center of USC
      • Contact: Pui Yan, MS; Phone Number: (323) 442-6984; Email: puiyan@med.usc.edu
      • Principal Investigator: Joseph Patterson, MD
    • Los Angeles, California, United States, 90048
      • Recruiting
      • Cedars-Sinai Medical Center
      • Principal Investigator: Geoffrey Marecek, MD
      • Contact: Geoffrey Marecek, MD; Phone Number: 310-423-4566; Email: Geoffrey.Marecek@cshs.org
    • Los Angeles, California, United States, 90033
      • Recruiting
      • Los Angeles General Medical Center
      • Contact: Pui Yan, MS; Phone Number: 323-442-6984; Email: puiyan@med.usc.edu
      • Principal Investigator: Joseph Patterson, MD
    • Sacramento, California, United States, 95817
      • Recruiting
      • University of California, Davis
      • Principal Investigator: Augustine Saiz, MD
      • Contact: Augustine Saiz, MD; Phone Number: 916-734-2182; Email: saizamjr@gmail.com
    • San Francisco, California, United States, 94143
      • Recruiting
      • University of California San Francisco
      • Principal Investigator: Saam Morshed, MD
      • Contact: Saam Morshed, MD; Phone Number: 415-647-3733; Email: Saam.Morshed@ucsf.edu
  • Indiana
    • Indianapolis, Indiana, United States, 46202
      • Recruiting
      • Indiana University
      • Contact: Yohan Jang, MD; Phone Number: 317-963-1966; Email: jangyoha@iu.edu
      • Principal Investigator: Yohan Jang, MD
  • Maryland
    • Baltimore, Maryland, United States, 21201
      • Recruiting
      • University of Maryland, Baltimore - R Adams Cowley Shock Trauma Center
      • Principal Investigator: Mark Gage, MD
      • Contact: Mark Gage, MD; Phone Number: 410-328-1868; Email: mgage@som.umaryland.edu
  • Massachusetts
    • Boston, Massachusetts, United States, 02114
      • Not yet recruiting
      • Massachusetts General Hospital
      • Contact: Arun Aneja, MD; Phone Number: 617-726-9111; Email: aaneja@mgh.harvard.edu
      • Principal Investigator: Arun Aneja, MD
  • Missouri
    • Columbia, Missouri, United States, 65201
      • Recruiting
      • The Curators of the University of Missouri - Missouri Orthopaedic Institute
      • Contact: Brett Crist, MD; Phone Number: 573-882-6562; Email: cristb@health.missouri.edu
      • Principal Investigator: Brett Crist, MD
  • Utah
    • Salt Lake City, Utah, United States, 84112
      • Recruiting
      • University of Utah
      • Contact: Lucas Marchand, MD; Phone Number: 801-581-2121; Email: Lucas.Marchand@hsc.utah.edu
      • Principal Investigator: Lucas Marchand, MD
  • Washington
    • Seattle, Washington, United States, 98104
      • Recruiting
      • University of Washington - Harborview Medical Center
      • Contact: Reza Firoozabadi, MD; Phone Number: 206-744-3298; Email: rezaf2@uw.edu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Patient 60 years of age or older.
2. Low energy injury mechanism defined as a fall from standing height.
3. LC1 pelvis fracture (AO/OTA 61B1.1 or 61B2.1) confirmed with antero-posterior, inlet, and outlet pelvis radiographs, computed tomography, or magnetic resonance imaging.
4. Fracture pattern that could be, in the judgment of the attending surgeon, managed with either early internal fixation or nonoperative care with early rehabilitation.
5. Fracture displacement of <10 mm of the posterior pelvic ring on computed tomography of the pelvis.
6. Injury occurred within 21 days of screening.

Exclusion Criteria:

1. Patient did not ambulate prior to injury.
2. Patient has another condition, injury, or fracture that prevents post-operative weightbearing on any extremity.
3. Retained implants around the pelvis that precludes or limits either study treatment.
4. Infection around the hip (soft tissue or bone).
5. Pathologic fracture with a lytic lesion in the pelvis or sacrum that precludes internal fixation.
6. Patient is too ill, in the judgement of the attending surgeon, for internal fixation.
7. Patient is too ill, in the judgement of the attending surgeon, for nonoperative care.
8. Problems, in the judgment of study personnel, with maintaining follow-up with the patient.
9. Expected injury survival of less than 12 months.
10. Terminal illness with expected survival of less than 12 months.
11. Currently enrolled in a study that does not permit co-enrollment.
12. Prior enrollment in the trial.
13. Unable to obtain informed consent due to language barriers.
14. Unable to obtain informed consent because a legally authorized representative (LAR) was unavailable.
15. Did not provide informed consent (declined participation).
16. Patient or LAR not approached to participate in the trial (missed patient).
17. Other reason to exclude the patient, as approved by the Methods Centre.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Early Internal Fixation; Early internal fixation of the LC1 fragility fracture of the pelvis will be defined as percutaneous anterior and/or posterior pelvic internal fixation with cannulated screw(s), medullary implant(s), or sacroiliac joint fusion device(s).	Procedure: Early Internal Fixation; Early internal fixation of the LC1 fragility fracture of the pelvis will be defined as percutaneous anterior and/or posterior pelvic internal fixation with cannulated screw(s), medullary implant(s), or sacroiliac joint fusion device(s). The implant number, design, diameter, thread type (fully-threaded or partially-threaded), sacral segment (S1, S2, S3, or any combination there of), length, trajectory including sacroiliac or transsacral-transiliac, application with or without a washer, and ingrowth or ongrowth surface designs will be at the discretion of the treating surgeon.
Active Comparator: Nonoperative Care with Early Rehabilitation; Nonoperative care with early rehabilitation will consist of nonoperative treatment of the pelvis fracture, including early consultation of the physical therapist, physiotherapist, or local equivalent rehabilitation provider at the time of randomization for a first attempt at mobilization of the patient within 24 hours of randomization	Other: Nonoperative Care with Early Rehabilitation; Nonoperative care with early rehabilitation will consist of nonoperative treatment of the pelvis fracture, including early consultation of the physical therapist, physiotherapist, or local equivalent rehabilitation provider at the time of randomization for a first attempt at mobilization of the patient within 24 hours of randomization. Patients who are unable to ambulate with assistance after five or more days of attempted mobilization by rehabilitation providers may be considered for delayed internal fixation treatment at the discretion of the patient and the treating surgeon. Delayed internal fixation after five or more days of attempted mobilization by rehabilitation providers will not be considered a treatment crossover event.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of participant enrollment	Proportion of patients who provide informed consent	12 months post-randomization
Feasibility of adherence to treatment allocation	Proportion of Adherence to early internal fixation treatment allocation and nonoperative care with early rehabilitation treatment allocation	12 months post-randomization
Refine data collection methods	Proportion of participants with missing data for the primary composite outcome	12 months post-randomization
Assess Protocol Compliance	Proportion of randomization errors	12 months post-randomization

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Composite hierarchical outcome of mortality, ambulation, and health days at home.	The secondary outcome (clinical primary outcome) will be a composite endpoint that will hierarchically assess its components in the following order: 1) mortality, 2) ambulation, and 3) healthy days at home. Mortality will consist of all causes of death. Ambulation will be defined as the ability of the patient to ambulate 10 feet or across the room a) without a walking aid or human assistance, b) with a waking aid and without human assistance, c) with human assistance, or d) unable to ambulate. Healthy days at home will be defined by subtracting the following measure components from the number of days in the time frame: mortality days, the total number of days spent in inpatient, observation, skilled nursing facilities (SNF), inpatient psychiatry, inpatient rehabilitation and long-term hospital settings as well as the number of outpatient emergency department and home health visits. The secondary outcomes will be assessed by a per-protocol analysis.	4 months post-randomization

Collaborators and Investigators

• Sponsor: University of Southern California
• Collaborators: University of Maryland, Baltimore; McMaster University; Orthopaedic Trauma Association
• Investigators: Principal Investigator: Joseph Patterson, MD, University of Southern California

Study record dates

Study Major Dates

• Study Start (Actual): November 12, 2024
• Primary Completion (Estimated): December 31, 2026
• Study Completion (Estimated): December 31, 2027

Study Registration Dates

• First Submitted: June 17, 2024
• First Submitted That Met QC Criteria: July 3, 2024
• First Posted (Actual): July 11, 2024

Study Record Updates

• Last Update Posted (Estimated): October 15, 2025
• Last Update Submitted That Met QC Criteria: October 10, 2025
• Last Verified: October 1, 2025

More Information

Terms related to this study

• Keywords: Older Adults; Physical Therapy; Early; Fragility Fracture; Internal Fixation; Pelvis Fracture; Lateral Compression type 1; Nonoperative Care
• Additional Relevant MeSH Terms: Wounds and Injuries; Leg Injuries; Fractures, Bone; Femoral Fractures; Hip Injuries; Hip Fractures
• Other Study ID Numbers: HS-24-00309

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No